Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move
(NYSE: $ACB) (TSX: $ACB.TO) (CSE: $DIXI_U.C) (OTCQX: $DXBRF) (TSXV: $META.V)
(CSE: $HITI.C) (TSXV: $PCLO.V)
Delta, Kelowna, BC –July
25, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/07251ACB-DIXI-DXBRF-META-HITI-PLCO.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), and the UFC announced the launch of a joint clinical research
program that will produce multiple studies under the terms of their recently
announced partnership.
The
research will examine the use of hemp-derived CBD as an effective treatment for
pain, inflammation, wound-healing, and recovery on MMA athletes.
The
ground-breaking research partnership is aimed at understanding key health and
recovery needs of elite athletes in such a highly physical and competitive
sport as mixed martial arts. Research data will then be used to drive the
development of science-backed, hemp-derived CBD topicals that will be safe and
reliable. These new products will help combat the rapidly growing market of
untested CBD treatments currently being used by high-performance and
non-professional athletes.
Once
research is complete, any resulting product will come to life in the U.S. under
the new high-performance sports brand ROAR Sports, a portfolio of high-quality,
hemp-derived CBD topical treatments scientifically formulated with elite
athletes in mind. Through analysis of athlete needs and scientific data, ROAR
Sports will challenge the status quo, seek to alleviate the stresses of
competition, and earn designation as the "Official CBD product of
UFC."
The
multi-phase clinical study at the UFC Performance Institute® in Las
Vegas will be led by Dr. Jason Dyck, Chair of Aurora's Global Scientific Oversight
Committee; Dr. Kelly Narine, Aurora's Vice President Global Research and
Medical Affairs; and the team of sports performance experts at the UFC
Performance Institute, led by Dr. Duncan French, UFC Vice President of
Performance. Using active UFC athletes on a strictly voluntary basis, the study
will help establish peer-reviewed, publishable research in this area. Products
will be developed in full compliance with U.S. federal law and with UFC's
anti-doping program, which adheres to WADA and USADA regulations.
"Our
partnership with UFC is about committing to the science that will educate and
advocate," said Aurora CEO Terry Booth. "We are going to work
together to change the way people think, to change the industry, and to launch
the first hemp-derived CBD products that are backed by scientific research. The
brand-building and product development are all part of our move into the U.S.,
and in collaboration with UFC, and we intend to play a major role in that
market."
"We
know anecdotally that professional athletes across sports disciplines are
turning to hemp-derived CBD treatments to assist with physical recovery, with
varying degrees of success," added Jason Dyck, Chair of Aurora's Global
Scientific Oversight Committee. "The work we do in partnership with UFC
will create an evidence-based, science-backed pipeline of consistent, and
'clean' hemp-derived CBD topicals that the high-performance athletes of UFC can
rely on to treat the pain, inflammation, injury and other conditions associated
with competing at such a high level."
Dixie Brands Inc. (CSE: DIXI.U) (OTCQX: DXBRF) today announced a breakthrough in THC water solubility via
a proprietary emulsification technique and ingredient management process
offering marked improvements in uptake in cannabis-infused liquids.
Dixie
Brands will showcase the proprietary process via the launch of a new product
line of flavored and unflavored drink additives called FUSE in the fourth
quarter of this year. In addition, Dixie will implement the new process across
its existing line of award-winning beverages and tinctures as part of its
never-ending drive to deliver the best possible consumption experience to consumers,
a heritage going back nearly 10 years since the launch of the original Dixie
Elixir.
"Dixie
was among the first to market with a cannabis-infused beverage nearly a decade
ago, and we have remained at the forefront of research and development ever since,"
said Chuck Smith, CEO of Dixie Brands. "That focus on innovation has
enabled us to expand into 15 product categories, and like any other successful
CPG company, we are always striving to improve our product offerings. A
faster-acting formula is the next step in our ongoing quest to better serve our
patients and consumers."
Cannabis-infused
beverages offer a bridge for "canna-curious" consumers seeking an
alternative to alcohol. The millennial demographic has been driving a growth
trend in the category. By improving
uptake times and introducing FUSE drink additives that can enhance
non-alcoholic beverages, Dixie expects to increase the appeal of its products
to these consumers and expand its addressable market.
National Access
Cannabis Corp. (TSXV: META), today announced it has received two additional licences
from the Alberta Gaming, Liquor and Cannabis Commission to open cannabis retail
stores in Alberta. The retail stores will be located in Leduc and Calgary.
"With
seven new licences granted in Alberta since the lifting of the moratorium by
the AGLC on May 30th, we continue to expand our private cannabis retailing
footprint in Alberta," said Mark Goliger, CEO of NAC. "Today we have
the largest footprint of retail cannabis stores in Canada1, and we
expect to maintain this position by continuing to pursue expansion
opportunities, particularly in British Columbia and Ontario."
NAC
is the national leader in retail cannabis1. Currently operating in
three provinces, NAC has applied for licences in British Columbia and plans to
make applications for licences in Ontario. NAC's experienced team of retail
industry professionals is focused on achieving its business plan of having 40
operating stores by the end of calendar 2019, and 110 operating stores by the
end of calendar 2020.
High Tide Inc. (CSE:HITI) (OTCQB:HITIF) today announced that the Canna Cabana retail stores
located in the city of Beaumont, a franchised store located in Calgary and in
Lacombe all received their first deliveries of cannabis products from Alberta
Gaming, Liquor and Cannabis ("AGLC") and have begun selling recreational
cannabis for adult use. The New Alberta Stores bring the total number of Canna
Cabana retail locations currently selling recreational cannabis to a total of
14 branded locations across Canada.
High
Tide expects its next 7 Canna Cabana locations and the first KushBar location
to be licensed as retail cannabis stores by the end of August, which will bring
its total number to 22 locations across Canada, barring any changes to the
current rate of licensing by AGLC.
"Bringing
the Canna Cabana experience to the community of Kensington in Calgary and the
cities of Beaumont and Lacombe not only supports the expansion of High Tide's
retail segment but it also boosts the wholesale segment as these locations
feature our wide range of proprietary smoking accessories," said Raj
Grover, President and Chief Executive Officer of High Tide. "Out staff is
excited to sell recreational cannabis products at the New Alberta Stores and we
look forward to continuing the rapid rate of growth that has taken Canna Cabana
from 4 to 10 Alberta locations within a month," added Mr. Grover.
The
remaining Canna Cabana and KushBar locations needed to achieve the AGLC's
maximum of 15% market share are currently under various stages of development
and construction. Outside of Alberta, High Tide currently has a Canna Cabana
retail cannabis store in Swift Current, Saskatchewan, along with 3 branded
locations in Hamilton, Sudbury and Toronto, Ontario. High Tide is also
progressing toward closing the previously announced acquisition of a second
location in Saskatchewan, establishing a retail cannabis presence in Manitoba
and opening the maximum number of 8 locations in British Columbia.
PharmaCielo Ltd. (TSXV:PCLO) (OTC:PHCEF), the Canadian parent of Colombia's
premier cultivator and producer of medicinal-grade cannabis extracts,
PharmaCielo Colombia Holdings S.A.S., announced today that it has completed the necessary
permitting process required to enable Colombia's first commercial export and
sale of non-psychoactive (CBD) isolate.
The
extensive process fulfils the extensive and final regulatory obligations
required, including individual approvals by the Colombian Ministries of Health
and Justice, in order to commence product exportation. With this prerequisite accomplished, the
Company will begin the process of confirming a series of international business
relationships and configuring inaugural commercial shipments of high-grade
medicinal CBD isolate, with a purity certificate of analysis (COA) of 99+% and
meeting all other strict quality control standard requirements established by
the Colombian government.
"Enabling
product delivery to customers is one of the most exciting and memorable moments
for any company, and we are thrilled about this accomplishment," said
David Attard, CEO of PharmaCielo Ltd. "This specific point in time not
only distills the vision, hard work, dedication and commitment of our team, but
also signifies the transition of PharmaCielo from a founding stage into a
mature company with the infrastructure of production, distribution and sales
operations that can deliver high-quality products to its clients."
PharmaCielo
is currently in advanced discussion with previously identified potential
customers in multiple global markets, as part of which the export permitting
process is a necessity, including logistical relations with its joint venture
partners in Italy and Mexico. Upon
closure of the acquisition of Creso Pharma Ltd., expected later in the year,
the number of potential international markets for PharmaCielo products export
will significantly increase.
"We
have already begun scaling up our Colombian operations and we are ready to
deliver and prepared to support the expected growth in demand for our
cannabinoid extracts, having achieved the Colombian industry's first go-ahead
to start exporting," said Andres Botero, Chief Operations Officer with
PharmaCielo Colombia Holdings S.A.S.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
